. . . . . . . . "21332310" . . . . . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@nl . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@nl . . "10.2217/PGS.10.172" . . "Clara Lemos" . . . "wetenschappelijk artikel"@nl . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u044E\u0442\u043E\u043C\u0443 2011"@uk . . . . . . . "159-170" . . . . . . . . . . "12" . . . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@en . . . . "Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@en . . "Yehuda G Assaraf" . . . . . . . . . . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@en . . . . . . . . . . . . . . . . . . . . . . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@nl . "Tahar van der Straaten" . . . . "2" . . . "George L Scheffer" . . "article"@en . . . . . . . . . . . . . . . . . "2011-02-01T00:00:00Z"^^ . . . . . . . . . . . "Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients"@en . . . . . . . . . . . . . . .